Stock Events

Stock Events

Terns Pharmaceuticals (430.F) Q4 2024 Earnings

12NovConfirmed

Q4 2023

Q2 2024

Q3 2024

Q4 2024

-0.32

-0.3

-0.28

-0.26

Details

Expected EPS

-0.30185447114999997

Actual EPS

-0.26374600000000004

Surprise EPS

0.04

Surprise Percent

+12.62%

Description

Terns Pharmaceuticals (430.F) has reported earnings of -0.26374600000000004 per share for Q4 2024.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.